Promoter holding
64.27%
ML
Micro Life Sciences Private Limited - Due diligence report
A 360° intelligence report on Micro Life Sciences: trust score, financial health, credit view, compliance, directors, growth and distress si…
ML
Micro Life Sciences Private Limited
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹349
50% off
New user
Or enjoy up to 50% off with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Micro Life Sciences — 360° Intelligence Report
Generated from MCA filings & public records88/100
Trust Score
Low Risk
Micro Life Sciences is assessed as Low Risk with a Trust Score of 88/100. Micro Life Sciences is an active private limited indian non-government company incorporated in 2006, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 09 Jul 2026 from the latest processed filings. Micro Life Sciences Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
88/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Consolidated · 3 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (AA).
Charges position: 7 open (1,237.00 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 3 | 48.0 cr |
| Others | 3 | 48.0 cr |
| State Bank Of India | 1 | 48.0 cr |
Compliance Score: 75/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 1 court forum(s).
- 1 auditor resignation(s) filed - latest: GOPALAKRISHNAN AIYER & CO. on 2015-12-23.
- Delayed payments to MSME suppliers disclosed (6 disclosure(s)).
- 8 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 90/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| VIVEK PRAFULBHAI SHAH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRAMODKUMAR MINOCHA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ALPESH MANSUKHLAL CHANIYARA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| NARENDRA OSTAWAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DINESH SARAF | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 5 directors on the board.
- No disqualified or deactivated DINs.
- 2 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2022 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
5
Group entities
5
Capital events
11 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Meril Australia Pty. Ltd. | Subsidiary Company | 74.00% |
| Meril Cardiology Pty. Ltd, South Africa (formely Known As Condor Medical Africa Pty. Ltd.) | Subsidiary Company | 74.00% |
| Meril China (co.) Ltd | Subsidiary Company | 74.00% |
| Meril Diagnostics Private Limited | Subsidiary Company | 74.00% |
| Meril Endo Surgery Private Limited | Subsidiary Company | 74.00% |
| Meril Gmbh | Subsidiary Company | 74.00% |
| Meril Healthcare Private Limited | Subsidiary Company | 74.00% |
| Meril Inc | Subsidiary Company | 74.00% |
| Meril Life Sciences India Private Limited | Subsidiary Company | 74.00% |
| Meril Life Sciences Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: VIVEK PRAFULBHAI SHAH (Whole-time director) · PRAMODKUMAR MINOCHA (Whole-time director) · DINESH SARAF (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 95 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 2 year(s).
Latest year revenue grew 24%.
Profit expanded 0.86 year-on-year.
Asset base grew 61% - capacity expansion.
Net margin improved to 38%.
EPFO headcount growing - hiring signal.
Operating for 20+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
7 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 5.43 Lakh.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence83/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment90/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 7 open charge(s) of 1,237.00 cr already registered.
- Compliance record supports lending.
Investor view93/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 6 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events11 Aug 2025
Last AGM held
Annual general meeting
30 Jun 2025
Charge created
Others - 250.00 cr
31 Mar 2025
Latest balance sheet
Filed with ROC
26 Mar 2025
Charge created
Hdfc Bank Limited - 188.00 cr
01 Jan 2025
Charge created
Hdfc Bank Limited - 389.00 cr
03 Sep 2024
Director ceased
NARENDRA OSTAWAL
29 Jun 2024
Charge created
Others - 250.00 cr
24 Apr 2024
Director appointed
ALPESH MANSUKHLAL CHANIYARA (Company Secretary)
15 Feb 2024
Director appointed
NARENDRA OSTAWAL (Director)
24 Nov 2023
Charge created
Hdfc Bank Limited - 100.00 cr
15 Nov 2023
Director ceased
PRASHANT ARUNKUMAR MEHTA
23 May 2023
Charge created
State Bank Of India - 50.00 cr
14 Feb 2023
Charge created
Others - 10.00 cr
25 May 2022
Director ceased
VISHAL KASHYAP MAHADEVIA
01 Jan 2022
Director appointed
DINESH SARAF (Whole-time director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 1.42 over the last 2 financial year(s).
Net profit margin moved from 2.1x to 24%.
Debt-to-equity stands at 0.86 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
8 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 5 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of AA from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 11 security allotment(s) - amounts available in the full report.
7 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Linc Pen & Plastics | L36991WB1994PLC065583 | Kolkata, West Bengal, India |
| Timex Group India | L33301DL1988PLC033434 | New Delhi, Delhi, India |
| Gna Gears Limited | U34300PB1980PLC004154 | Jalandhar, Punjab, India |
| Sawansukha Jewellers | U51398WB1995PTC074603 | Kolkata, West Bengal, India |
| Moksh | L36996MH2012PLC233562 | Mumbai, Maharashtra, India |
| Radhika Jeweltech | L27205GJ2016PLC093050 | Rajkot, Gujarat, India |
| Studds | L25208HR1983PLC015135 | Faridabad, Haryana, India |
| Healthium | U03311KA1992PLC013831 | Bangalore, Karnataka, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Micro Life Sciences before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Micro Life Sciences: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Micro Life Sciences - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 88/100, distress signals and MSME payment-delay disclosures - know whether Micro Life Sciences pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Micro Life Sciences - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Micro Life Sciences an active company?
Micro Life Sciences has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Micro Life Sciences financially healthy?
Micro Life Sciences has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Micro Life Sciences?
Its overall Trust Score is 88/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Micro Life Sciences?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.
Does Micro Life Sciences have loans or charges against its assets?
7 open charge(s) are registered against its assets.
Is Micro Life Sciences up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Micro Life Sciences?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
